ACP Journal Club. Review: Varenicline is better than placebo or bupropion, but not clearly different from the nicotine patch, for smoking abstinence

Comment

James Brophy. Ann Intern Med. 2011.

. 2011 Apr 19;154(8):JC4-4.

doi: 10.7326/0003-4819-154-8-201104190-02004.

No abstract available

Comment on

Nicotine receptor partial agonists for smoking cessation.
Cahill K, Stead LF, Lancaster T. Cahill K, et al. Cochrane Database Syst Rev. 2011 Feb 16;(2):CD006103. doi: 10.1002/14651858.CD006103.pub5. Cochrane Database Syst Rev. 2011. Update in: Cochrane Database Syst Rev. 2012 Apr 18;(4):CD006103. doi: 10.1002/14651858.CD006103.pub6. PMID: 21328282 Updated.

ACP Journal Club. Review: varenicline is better than bupropion but not nicotine patch for smoking abstinence in adults.
Prochazka AV, Caverly TJ. Prochazka AV, et al. Ann Intern Med. 2012 Sep 18;157(6):JC3-7. doi: 10.7326/0003-4819-157-6-201209180-02007. Ann Intern Med. 2012. PMID: 22986399 No abstract available.
A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation.
Jorenby DE, Leischow SJ, Nides MA, Rennard SI, Johnston JA, Hughes AR, Smith SS, Muramoto ML, Daughton DM, Doan K, Fiore MC, Baker TB. Jorenby DE, et al. N Engl J Med. 1999 Mar 4;340(9):685-91. doi: 10.1056/NEJM199903043400903. N Engl J Med. 1999. PMID: 10053177 Clinical Trial.
Varenicline in the management of smoking cessation: a single technology appraisal.
Hind D, Tappenden P, Peters J, Kenjegalieva K. Hind D, et al. Health Technol Assess. 2009 Sep;13 Suppl 2:9-13. doi: 10.3310/hta13suppl2/02. Health Technol Assess. 2009. PMID: 19804684 Review.
Varenicline: new drug. Smoking cessation: no better than nicotine.
[No authors listed] [No authors listed] Prescrire Int. 2006 Dec;15(86):210-2. Prescrire Int. 2006. PMID: 17165237
Efficacy and safety of varenicline for smoking cessation.
Hays JT, Ebbert JO, Sood A. Hays JT, et al. Am J Med. 2008 Apr;121(4 Suppl 1):S32-42. doi: 10.1016/j.amjmed.2008.01.017. Am J Med. 2008. PMID: 18342165 Review.